MCCULLOCH KEVIN (See Remarks) reported 1 transaction at XERIS BIOPHARMA HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/3/2025ACC: 0002031695-25-000006
Officer· See Remarks
Since Mar 2026
-733.00
Net shares
Net seller
$6.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
733.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−733.00
Price / share
$8.31
Trade value
$6.09K
% of position
0.0%
10/2/2025
1.70M→1.70M
Total
Net shares
−733.00
Net value
-$6.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/2/2025 | F · Tax Withholding | −733.00 | $8.31 | $6.09K | 0.0% | 1.70M | 1.70M |
| Total | −733.00 | -$6.09K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned25K
Total
25K indirect25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25K | Indirect |
| Total | 25K | 25K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported